Paper3970478
The quinolones.
Fass RJ. Ann Intern Med, 1985. Cited by 43 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The quinolones. Papers, record 3970478. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3970478
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nalidixic Acid | Major topic |
| Urinary Tract Infections | Major topic |
| Gram-Negative Bacteria | |
| Humans |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,878,593 | Intestinal elimination of ofloxacin enantiomers in the rat: evidence of a carrier-mediated process. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8878593 | PubMed |
| 8,513,819 | Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour. | Eur J Clin Microbiol Infect Dis | 1993 | https://conductscience.org/library/papers/8513819 | PubMed |
| 3,566,244 | Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3566244 | PubMed |
| 3,479,046 | Pharmacokinetics of ofloxacin after parenteral and oral administration. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3479046 | PubMed |
| 3,143,584 | Comparative in vitro activity of the two new 4-quinolones S-25930 and S-25932 against gram-positive bacteria isolated from cancer patients. | Eur J Clin Microbiol Infect Dis | 1988 | https://conductscience.org/library/papers/3143584 | PubMed |
| 3,000,292 | The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3000292 | PubMed |
| 2,942,102 | Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/2942102 | PubMed |
| 2,938,072 | Quinolones and colonization resistance in human volunteers. | Pharm Weekbl Sci | 1986 | https://conductscience.org/library/papers/2938072 | PubMed |
| 2,680,058 | Fluoroquinolone antimicrobial agents. | Clin Microbiol Rev | 1989 | https://conductscience.org/library/papers/2680058 | PubMed |
| 1,917,050 | Rufloxacin once daily in acute exacerbations of chronic bronchitis. | Infection | 1991 | https://conductscience.org/library/papers/1917050 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3970478
GET https://conductscience.org/api/papers/v1/3970478/authors